在中国动作频频,礼来正在全力押注AI制药赛道

动脉网
Nov 10, 2025

在GLP-1领域竞争加剧背景下,礼来全力押注AI制药赛道以构建差异化优势。11月8日,礼来上海创新孵化器运营,并与三家本土企业达成战略合作。其中,英硅智能Pharma.AI平台效能惊人,双方将聚焦创新靶点化合物设计与优化。近半月,礼来AI布局“三连击”:与Ailux达成3.45亿美元合作加码AI抗体研发,联合英伟达打造制药“超级计算机”,推出自研AI平台TuneLab。礼来正构建多层次AI创新生态...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10